发明名称 Quinazoline derivative
摘要 This invention provides a compound or its pharmaceutically-acceptable salt of formula (I) wherein R1 represents a lower alkyl group et al; R2 and R3 are same and different and represents hydrogen atm et al; R4 represents the substituent of the formula (II) et al; X1 represents NH, O or S; Y represents N or C; Ar is a divalent substituent derived from aryl et al, by removing two hydrogen atoms therefrom; the ring A represents a 5- or 6-membered heteroaryl group; this compounds has a histamine-H3 receptor antagonistic effect or a histamine-H3 receptor inverse-agonistic effect and is useful for preventive or remedy of metabolic system diseases, circulatory system diseases or nervous system diseases.
申请公布号 US7960394(B2) 申请公布日期 2011.06.14
申请号 US20050628087 申请日期 2005.05.30
申请人 BANYU PHARMACEUTICAL CO., LTD. 发明人 MIZUTANI TAKASHI;NAGASE TSUYOSHI;SATO NAGAAKI;KANATANI AKIO;TOKITA SHIGERU
分类号 A01N43/00;A61K31/517;A61K31/519;A61P1/16;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P9/00;A61P9/10;A61P9/12;A61P13/12;A61P25/00;A61P25/02;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P25/36;A61P43/00;C07D239/70;C07D239/91;C07D401/12;C07D403/04;C07D471/04 主分类号 A01N43/00
代理机构 代理人
主权项
地址